WHO Endorses Cepheid's TB Test | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The World Health Organization today endorsed Cepheid's Xpert MTB/RIF test for rapid testing of tuberculosis, calling it "a major milestone for global TB diagnosis and care."

WHO is now calling for the fully-automated nucleic acid amplification test to be rolled out under defined conditions as part of national plans for TB and multi-drug resistant TB care and control.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.